Detalles de la búsqueda
1.
A self-amplifying mRNA SARS-CoV-2 vaccine candidate induces safe and robust protective immunity in preclinical models.
Mol Ther
; 30(5): 1897-1912, 2022 05 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34990810
2.
Convergent structural features of respiratory syncytial virus neutralizing antibodies and plasticity of the site V epitope on prefusion F.
PLoS Pathog
; 16(11): e1008943, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33137810
3.
Chimeric hemagglutinin supra-seasonal universal influenza vaccine candidates administered sequentially by the intramuscular route are locally and systemically well-tolerated in rabbits.
Regul Toxicol Pharmacol
; 113: 104625, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32119974
4.
Structural and computational design of a SARS-CoV-2 spike antigen with improved expression and immunogenicity.
Sci Adv
; 9(23): eadg0330, 2023 06 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37285422
5.
The RSVPreF3-AS01 vaccine elicits broad neutralization of contemporary and antigenically distant respiratory syncytial virus strains.
Sci Transl Med
; 15(710): eadg6050, 2023 08 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-37611082
6.
Impact of mutations at residue I223 of the neuraminidase protein on the resistance profile, replication level, and virulence of the 2009 pandemic influenza virus.
Antimicrob Agents Chemother
; 56(3): 1208-14, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22203589
7.
Oseltamivir-resistant pandemic A/H1N1 virus is as virulent as its wild-type counterpart in mice and ferrets.
PLoS Pathog
; 6(7): e1001015, 2010 Jul 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-20661429
8.
Reactogenicity, safety, and immunogenicity of chimeric haemagglutinin influenza split-virion vaccines, adjuvanted with AS01 or AS03 or non-adjuvanted: a phase 1-2 randomised controlled trial.
Lancet Infect Dis
; 22(7): 1062-1075, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35461522
9.
Influenza A(H7N9) Pandemic Preparedness: Assessment of the Breadth of Heterologous Antibody Responses to Emerging Viruses from Multiple Pre-Pandemic Vaccines and Population Immunity.
Vaccines (Basel)
; 10(11)2022 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36366364
10.
AS03-adjuvanted H7N9 inactivated split virion vaccines induce cross-reactive and protective responses in ferrets.
NPJ Vaccines
; 6(1): 40, 2021 Mar 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-33742000
11.
Technological approaches to streamline vaccination schedules, progressing towards single-dose vaccines.
NPJ Vaccines
; 5: 88, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33024579
12.
Formulation Design, Optimization and In Vivo Evaluations of an α-Tocopherol-Containing Self-Emulsified Adjuvant System using Inactivated Influenza Vaccine.
J Control Release
; 316: 12-21, 2019 12 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-31678654
13.
Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohorts.
NPJ Vaccines
; 4: 51, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31839997
14.
Chimeric Hemagglutinin-Based Influenza Virus Vaccines Induce Protective Stalk-Specific Humoral Immunity and Cellular Responses in Mice.
Immunohorizons
; 3(4): 133-148, 2019 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31032479
15.
Heterologous prime-boost with A(H5N1) pandemic influenza vaccines induces broader cross-clade antibody responses than homologous prime-boost.
NPJ Vaccines
; 4: 22, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31149353
16.
Editorial: Pandemic influenza vaccine approaches: Current status and future directions.
Front Immunol
; 13: 980956, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36059549
17.
Low hemagglutinin antigen dose influenza vaccines adjuvanted with AS03 alter the long-term immune responses in BALB/c mice.
Hum Vaccin Immunother
; 13(3): 561-571, 2017 03 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-27768511
18.
Evaluation of the potential effects of AS03-adjuvanted A(H1N1)pdm09 vaccine administration on the central nervous system of non-primed and A(H1N1)pdm09-primed cotton rats.
Hum Vaccin Immunother
; 13(1): 90-102, 2017 01 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27629482
19.
An Intranasal Proteosome-Adjuvanted Trivalent Influenza Vaccine Is Safe, Immunogenic & Efficacious in the Human Viral Influenza Challenge Model. Serum IgG & Mucosal IgA Are Important Correlates of Protection against Illness Associated with Infection.
PLoS One
; 11(12): e0163089, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-28005959
20.
Impact of a large deletion in the neuraminidase protein identified in a laninamivir-selected influenza A/Brisbane/10/2007 (H3N2) variant on viral fitness in vitro and in ferrets.
Influenza Other Respir Viruses
; 10(2): 122-6, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26526406